Q4338 identifies Artacent Velos; Q4339 identifies Artacent Vericlen. Match the code to the product used.
On this page
CMS RVU26D · Effective 2026-10-01
Q4339 Wound matrix Medicare reimbursement rates in Virginia
Reports Artacent Vericlen wound matrix by square centimeter when the product is supplied for application during a wound treatment procedure. Compare Q4339 office and facility rates across CMS payment localities in Virginia.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4339 in Virginia?
Virginia has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
$125.09–$149.91
2 of 2 localities have a supported rate.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care
About Q4339: Artacent Vericlen wound matrix
Reports Artacent Vericlen wound matrix by square centimeter when the product is supplied for application during a wound treatment procedure.
Q4339 identifies the Artacent Vericlen product used as a wound covering. It reports the product quantity by square centimeter, not the clinician’s work to prepare the wound or apply the material. Clinicians who perform wound procedures, including wound-care specialists and surgeons, may use it in outpatient wound clinics or surgical settings when this product is applied to a wound.
Report Q4339 with the primary procedure for the wound application; it is not submitted by itself. Record the product name, wound site, area represented by the units, and the associated application procedure. CMS treats Q4339 as an add-on paid within the primary procedure’s global period. CMS also classifies it as technical-component-only, with interpretation covered by a separate code.
CMS billing rules for Q4339
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4339 compared with similar codes
Office rates for Virginia, from the same CMS release.
Q4336 identifies Artecent C, a different product. Q4339 is specific to Artacent Vericlen.
Q4337 identifies Artecent Trident rather than Artacent Vericlen. The product identifier, not the wound site, distinguishes these codes.
15271 reports the wound application procedure for qualifying trunk, arm, or leg sites; Q4339 reports the Artacent Vericlen product supplied with a primary procedure.
Compare Q4339 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Dc + Md/Va Suburbs →
Office / nonfacility
$149.91
Facility
Unavailable
Virginia →
Office / nonfacility
$125.09
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
Q4339 billing questions
Can Q4339 be billed by itself?
No. CMS identifies Q4339 as an add-on code that must be billed with a primary procedure.
How are units determined?
The code is reported per square centimeter of Artacent Vericlen. Document the product quantity and wound area supporting the units billed.
Does Q4339 report the wound application service?
No. Q4339 identifies the product. Report the appropriate primary wound-application procedure separately.
How does the global period affect Q4339?
CMS pays this add-on within the primary procedure’s global period. Submit it with that primary procedure rather than as a separate service.
How should Q4339 be distinguished from Q4338?
Q4339 identifies Artacent Vericlen, while Q4338 identifies Artacent Velos. Select the code that matches the product used, not simply the wound size.
Does Q4339 include interpretation?
CMS classifies Q4339 as technical-component-only; a separate code covers interpretation.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
